News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-11 6:1:31 am TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment GlobeNewsWire
2024-03-06 1:15:0 pm TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress GlobeNewswire
2024-02-20 5:0:0 am TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic GlobeNewswire
2024-01-31 1:5:0 pm Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market GlobeNewswire
2024-01-29 5:30:0 am TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer GlobeNewswire
2024-01-22 1:45:0 pm TransCode Therapeutics Announces Closing of $7.25 Million Public Offering GlobeNewswire
2024-01-19 10:9:0 am TransCode (RNAZ) Down 50% on Issue of New Common Stock Zacks
2024-01-18 10:27:0 am TransCode Therapeutics Announces Pricing of $7.25 Million Public Offering GlobeNewswire
2024-01-12 1:5:0 pm TransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information